Physician
Dematteo, Mark
Dematteo, Mark was paid $821K by Medicaid between Jun 2019 and Jan 2023, across 23 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 57% of everything it billed.
33Billing provider infoDEMATTEO, MARK
BRAINTREE, MA 02184
BRAINTREE, MA 02184
33aNPI1922044015assigned 06/20/2006
33bProvider typeEmergency Medicine Physician
28Total paid$821K
24GClaims10,147
24DCodes billed23
24AFirst – last monthJun 2019 – Jan 2023
Compared with peers
Next to other Emergency Medicine Physician providers in Massachusetts
Rank by total paid#25 of 618
Median peer was paid$8K
This provider vs. median99×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 1,496 | $66K | |
| 2020 | 1,395 | $98K | |
| 2021 | 3,113 | $353K | |
| 2022 | 3,892 | $287K | |
| 2023 | 251 | $18K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 57% | 1,936 | 1,893 | $469K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 2,294 | 2,253 | $194K |
| 87428 | 5.7% | 531 | 522 | $47K | |
| 99051 | 2.4% | 866 | 850 | $20K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.0% | 211 | 208 | $16K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.6% | 298 | 296 | $13K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.6% | 297 | 296 | $13K |
| 81025 | <1% | 824 | 815 | $8K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 406 | 402 | $8K |
| 87481 | <1% | 70 | 60 | $6K | |
| 81002 | <1% | 1,176 | 1,156 | $4K | |
| 81514 | <1% | 15 | 14 | $4K |
11 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 367 | $4K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 61 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 229 | $2K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 41 | $2K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 60 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 45 | $2K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 70 | $1K |
| 87081 | <1% | 120 | $1K | |
| 80053 | Comprehensive metabolic panel | <1% | 51 | $735.30 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 44 | $512.16 |
| 81003 | <1% | 135 | $400.46 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.